Drug Delivery Licensing Opportunities.

Inhaled drug delivery

Pharmaterials Respisolv® technology is a novel patented means of delivery of small and macromolecular drugs to the lung (or nasal delivery) using pressurised metered dose inhaler (pMDI) technology.  This technology is suitable for local delivery or systemic delivery.

Please contact us for more details of our licensing opportunities.